comparemela.com

Latest Breaking News On - தேசிய ஆரோக்கியம் ஆராய்ச்சி நிறுவனம் - Page 1 : comparemela.com

《TAIPEI TIMES》 Nation eyes Moderna production - 焦點

《TAIPEI TIMES》 Nation eyes Moderna production - 焦點
ltn.com.tw - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ltn.com.tw Daily Mail and Mail on Sunday newspapers.

Nation eyes Moderna production - Taipei Times

Nation eyes Moderna production - Taipei Times
taipeitimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from taipeitimes.com Daily Mail and Mail on Sunday newspapers.

Контакты помогают заключать контракты | Интервью, выступления, публикации | Официальный сайт Палаты Представителей Национального собрания Республики Беларусь

Контакты помогают заключать контракты | Интервью, выступления, публикации | Официальный сайт Палаты Представителей Национального собрания Республики Беларусь
house.gov.by - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from house.gov.by Daily Mail and Mail on Sunday newspapers.

DNA vaccine created new hope in war with Corona know about it

DNA vaccine created new hope in war with Corona know about it
jagran.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jagran.com Daily Mail and Mail on Sunday newspapers.

Adimmune slides into red on rising R&D expenditure

Adimmune slides into red on rising R&D expenditure By Kao Shih-ching / Staff reporter Vaccine maker Adimmune Corp (國光生技) yesterday reported a net loss of NT$249 million (US$8.91 million) for last quarter, compared with a net profit of NT$1.24 billion in the fourth quarter of last year, due to rising research and development (R&D) expenses that involved a phase 1 clinical trial for its experimental vaccine against COVID-19. That translates into a loss per share of NT$0.58, widening from minus-NT$0.05 a year earlier. Revenue last quarter sank 98 percent year-on-year to NT$6.9 million due to a high comparison base last year, it said.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.